Henry Schein Beats on Both Top and Bottom Lines

Henry Schein (Nasdaq: HSIC  ) reported earnings on May 8. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), Henry Schein beat expectations on revenues and earnings per share.

Compared with the prior-year quarter, revenue improved and GAAP earnings per share expanded.

Gross margins expanded, operating margins improved, net margins dropped.

Revenue details
Henry Schein reported revenue of $2.10 billion. The 12 analysts polled by S&P Capital IQ expected to see sales of $2.03 billion on the same basis. GAAP reported sales were 7.8% higher than the prior-year quarter's $1.95 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.98. The 15 earnings estimates compiled by S&P Capital IQ predicted $0.92 per share. GAAP EPS of $0.89 for Q1 were 8.5% higher than the prior-year quarter's $0.82 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 29.1%, 10 basis points better than the prior-year quarter. Operating margin was 6.9%, 50 basis points better than the prior-year quarter. Net margin was 3.8%, 10 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $2.19 billion. On the bottom line, the average EPS estimate is $1.10.

Next year's average estimate for revenue is $8.80 billion. The average EPS estimate is $4.32.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 94 members out of 103 rating the stock outperform, and nine members rating it underperform. Among 32 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 31 give Henry Schein a green thumbs-up, and one give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Henry Schein is hold, with an average price target of $75.54.

If you're interested in health-care stocks like Henry Schein, you might want to expand your horizons to find maximum returns. Follow the money and meet a prime candidate for major returns in our new report, "Discover the Next Rule-Breaking Multibagger." Get instant access to this free report.

Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings. He is the co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1882624, ~/Articles/ArticleHandler.aspx, 9/18/2014 5:16:40 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement